找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies; Innovations in Manag Zbigniew Petrovich (Professor of Radiation Oncolog

[复制链接]
查看: 12665|回复: 58
发表于 2025-3-21 17:17:08 | 显示全部楼层 |阅读模式
书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies
副标题Innovations in Manag
编辑Zbigniew Petrovich (Professor of Radiation Oncolog
视频video
概述the book provides current information on the etiology, diagnosis and treatment - well referenced, comprehensive update on the topics presented - provides good assistance to teaching - numerous illustr
丛书名称Medical Radiology
图书封面Titlebook: Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies; Innovations in Manag Zbigniew Petrovich (Professor of Radiation Oncolog
描述In the United States in 1997, 28800 new cases of malignant tumors of the kidney and renal pelvis were diagnosed along with 2100 new cases of malignant tumors of the ureter and other urinary organs, 7200 primary malignant tumors of the testis, and 1300 primary malignant tumors of the penis and other genital organs. In large measure, surgery is the treatment of choice for these tumors, but radiation therapy is in­ creasingly recognized as having significant and important curative and palliative bene­ fits in each of these tumor sites. Surgery is the standard form of treatment for non­ metastatic renal cell carcinomas as well as for malignancies of the renal pelvis and ureter, with radical nephrectomy and radical uretectomy being employed. However, postoperative radiation therapy is of value for those patients who demonstrate evi­ dence of residual tumor following surgery, transection of tumor during surgery, or positive regional lymph node drainage. As regards the rare tumors that involve the female urethra, surgical resection is appropriate for those that are limited and local in character and amenable to partial ureterectomy. With tumors that are more advanced in character, however
出版日期Book 1999
关键词Karzinom; Tumor; cancer; carcinoma; cell; diagnosis; fertility; genetics; imaging; kidney; molecular genetics;
版次1
doihttps://doi.org/10.1007/978-3-642-59839-5
isbn_softcover978-3-642-64144-2
isbn_ebook978-3-642-59839-5Series ISSN 0942-5373 Series E-ISSN 2197-4187
issn_series 0942-5373
copyrightSpringer-Verlag Berlin Heidelberg 1999
The information of publication is updating

书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies影响因子(影响力)




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies影响因子(影响力)学科排名




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies网络公开度




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies网络公开度学科排名




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies被引频次




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies被引频次学科排名




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies年度引用




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies年度引用学科排名




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies读者反馈




书目名称Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:16:36 | 显示全部楼层
发表于 2025-3-22 02:36:48 | 显示全部楼层
Imaging of Renal Parenchymal Tumorsons. Therefore, optimization of the imaging techniques is a continuous challenge for radiologists. Once a renal mass is detected, the radiologist is faced with two additional tasks: (1) to determine whether it is a simple renal cyst/benign lesion or a malignant tumor, or more simply, whether or not
发表于 2025-3-22 05:58:26 | 显示全部楼层
发表于 2025-3-22 10:14:59 | 显示全部楼层
Nephron-Sparing Surgerycancer, the mortality from kidney cancer can be estimated to be twice as high as that from bladder and 3 times as high as that from prostate cancer. The clinical picture of renal cell carcinoma has, however, changed completely during the last decade. Most tumors are no longer presenting at a locally
发表于 2025-3-22 14:00:46 | 显示全部楼层
Palliative Surgical Therapyetastatic disease at presentation. Following nephrectomy for apparently localized disease, 50% of patients will develop progression with the occurrence of distant metastases or locoregional recurrence. Most of these patients die within 1 year and the reported 5-year survival rates vary between 0% an
发表于 2025-3-22 19:47:10 | 显示全部楼层
发表于 2025-3-23 00:49:21 | 显示全部楼层
Immunotherapy and Chemotherapy for Metastatic Renal Cell Carcinomanosis (. et al. 1997). For these patients the prognosis is poor, with an estimated median survival of less than 1 year and an overall 5-year survival of less than 20% (. et al. 1991). Spontaneous remissions of metastatic lesions have on rare occasions been documented to occur after removal of the pr
发表于 2025-3-23 01:54:56 | 显示全部楼层
The Role of Radiotherapy in the Management of Patients with Renal Cell Carcinomaf all genitourinary tumors in incidence and 18% in mortality rates (. et al. 1998). Most (>80%) tumors of the kidneys are renal cell carcinomas (RCCs), which show a predilection to occur in males in their fifth and sixth decades of life, although this tumor is known to occur in much younger patients
发表于 2025-3-23 06:51:36 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 22:06
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表